Table 2.
Clinical outcomes of overall survival and ED/inpatient encounters for AF and CHF stratified by BMI and baseline statin use. Survival data is reported as number of subjects at risk (% surviving) (p-y = person-years).
|
BMI (kg/m2) category |
Statin Use |
Total (N = 2503) | |||||
|---|---|---|---|---|---|---|---|
|
Normal BMI 18.5–24.99 (N = 569) |
Overweight 25–29.99 (N = 720) |
Class 1–2 Obesity 30–39.99 (N = 832) |
Class 3 Obesity ≥40 (N = 382) |
No (N = 1136) |
Yes (N = 1367) | ||
| All-Cause Mortality | |||||||
| Follow-up time (years, median [Q1, Q3]) | 6.25 [4.99, 7.38] | 6.51 [5.24, 8.10] | 6.33 [5.24, 7.87] | 6.76 [5.30, 8.77] | 6.66 [5.33, 8.65] | 6.21 [5.10, 7.58] | 6.42 [5.20, 8.04] |
| Total no. events | 104 | 113 | 116 | 51 | 147 | 237 | 384 |
| Events per 100p-y | 2.88 | 2.32 | 2.09 | 1.88 | 1.85 | 2.69 | 2.29 |
| 5-year survival | 424 (89.5 %) | 579(91.0 %) | 668(92.0 %) | 316(94.5 %) | 932 (93.6 %) | 1055(89.8 %) | 1987 (91.5 %) |
| 10-year survival | 47(74.4 %) | 93(80.6 %) | 91(78.4 %) | 60(81.4 %) | 169 (83.2 %) | 122 (74.4 %) | 291 (78.7 %) |
| ED/Hospital Encounters | |||||||
| Follow-up time (years, median [Q1, Q3]) | 1.53 [0.36, 3.02] | 1.71 [0.59, 3.62] | 2.11 [0.80, 3.64] | 2.44 [0.71, 4.42] | 1.83 [0.60, 3.53] | 2.05 [0.64, 3.64] | 1.94 [0.61, 3.57] |
| Atrial fibrillation | |||||||
| Total no. events | 224 | 288 | 365 | 290 | 451 | 716 | 1167 |
| Events per 10p-y | 2.31 | 2.05 | 2.03 | 3.04 | 1.90 | 2.61 | 2.28 |
| Congestive heart failure | |||||||
| Total no. events | 180 | 235 | 351 | 261 | 305 | 722 | 1027 |
| Events per 10p-y | 1.86 | 1.67 | 1.96 | 2.74 | 1.28 | 2.63 | 2.01 |